EcoDrugPlus

Somatostatin Receptor 3

Ensembl ID : ENSMOCG00000001850
Gene Symbol: SSTR3
3 Cross references
249 Possible Orthologues:

Somatostatin Receptor 4

Ensembl ID : ENSMOCG00000004743
Gene Symbol: SSTR4
3 Cross references
100 Possible Orthologues:

Somatostatin Receptor 5

Ensembl ID : ENSMOCG00000009060
Gene Symbol: SSTR5
3 Cross references
256 Possible Orthologues:

Sphingosine Kinase 2

Ensembl ID : ENSMOCG00000015744
Gene Symbol: SPHK2
3 Cross references
209 Possible Orthologues:

Sphingosine-1-Phosphate Receptor 1

Ensembl ID : ENSMOCG00000019832
Gene Symbol: S1PR1
3 Cross references
200 Possible Orthologues:

Spleen Associated Tyrosine Kinase

Ensembl ID : ENSMOCG00000009978
Gene Symbol: SYK
3 Cross references
200 Possible Orthologues:

Squalene Synthase

Ensembl ID : ENSMOCG00000011046
Gene Symbol: LOC101980803
2 Cross references
214 Possible Orthologues:

Steroid 17-Alpha-Hydroxylase/17,20 Lyase

Ensembl ID : ENSMOCG00000003696
Gene Symbol: LOC101982961
3 Cross references
210 Possible Orthologues:

Steroid 5 Alpha-Reductase 2

Ensembl ID : ENSMOCG00000002408
Gene Symbol: SRD5A2
3 Cross references
263 Possible Orthologues:

Sterol O-Acyltransferase 1

Ensembl ID : ENSMOCG00000016867
Gene Symbol: SOAT1
3 Cross references
210 Possible Orthologues:

Stromelysin-1

Ensembl ID : ENSMOCG00000006156
Gene Symbol: LOC101986999
3 Cross references
493 Possible Orthologues:

Sucrase-Isomaltase

Ensembl ID : ENSMOCG00000020139
Gene Symbol: SI
3 Cross references
200 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).